Table 2.
Correlation analysis among oxidative stress markers and cardio-metabolic risk factors (Spearman's test).
| sRAGE | AGEs | AOPPs | AGEs/sRAGE | ||
|---|---|---|---|---|---|
| BMI SD | r | −0.52 | 0.72 | 0.46 | 0.42 |
| p | 0.000 | 0.53 | 0.000 | 0.000 | |
| WHtR | r | −0.2 | 0.07 | −0.01 | 0.19 |
| p | 0.21 | 0.65 | 0.95 | 0.22 | |
| TC | r | −0.10 | 0.08 | 0.09 | 0.19 |
| p | 0.38 | 0.47 | 0.50 | 0.09 | |
| LDL | r | −0.12 | 0.23 | 0.16 | 0.28 |
| p | 0.31 | 0.047 | 0.20 | 0.015 | |
| HDL | r | 0.30 | −0.17 | −0.47 | −0.33 |
| p | 0.008 | 0.15 | 0.000 | 0.004 | |
| TC/HDL–ratio | r | −0.33 | 0.23 | 0.47 | 0.41 |
| p | 0.004 | 0.044 | 0.000 | 0.000 | |
| TG | r | −0.05 | 0.15 | 0.52 | 0.14 |
| p | 0.65 | 0.23 | 0.000 | 0.24 | |
| TG/HDL-ratio | r | −0.18 | 0.20 | 0.54 | 0.25 |
| p | 0.12 | n.s. | 0.000 | 0.026 | |
| AIP | r | −0.18 | 0.19 | 0.54 | 0.25 |
| p | 0.11 | 0.09 | 0.000 | 0.028 | |
| HOMA-IR | r | −0.20 | −0.60 | 0.37 | 0.13 |
| p | 0.10 | 0.63 | 0.002 | 0.28 | |
| CRP | r | −0.26 | 0.23 | 0.39 | 0.40 |
| p | 0.02 | 0.044 | 0.000 | 0.007 | |
| Uric acid | r | −0.11 | 0.06 | 0.08 | 0.16 |
| p | 0.35 | 0.58 | 0.50 | 0.17 |
WHtR, Waist-to-height-ratio; TC, Total cholesterol; TG, Triglycerides; AIP, Atherogenic index of plasma; HOMA-IR, Homeostasis model assessment of insulin resistance; CRP, C-reactive protein; AGEs, Advanced glycation end-products; sRAGE, Circulating soluble AGE receptor; AOPPs, Advanced oxidation-protein products. Bold values indicate a statistically significant correlation.